z-logo
open-access-imgOpen Access
An orally bioavailable broad-spectrum antiviral inhibits SARS-CoV-2 in human airway epithelial cell cultures and multiple coronaviruses in mice
Author(s) -
Timothy P. Sheahan,
Amy Sims,
Shuntai Zhou,
Rachel L. Graham,
Andrea J. Pruijssers,
Maria L. Agostini,
Sarah R. Leist,
Alexandra Schäfer,
Kenneth H. Din,
Laura J. Stevens,
James D. Chappell,
Xiaotao Lu,
Tia M. Hughes,
Amelia S. George,
Collin S. Hill,
Stephanie A. Montgomery,
Ariane J. Brown,
Gregory R. Bluemling,
Michael G. Natchus,
Manohar Saindane,
Alexander A. Kolykhalov,
George R. Painter,
Jennifer L. Harcourt,
Azaibi Tamin,
Natalie J. Thornburg,
Ronald Swanstrom,
Mark R. Denison,
Ralph S. Baric
Publication year - 2020
Publication title -
carolina digital repository (university of north carolina at chapel hill)
Language(s) - English
DOI - 10.17615/xw2w-rr45
Subject(s) - virology , covid-19 , airway , microbiology and biotechnology , biology , coronavirus , cell culture , virus , broad spectrum , medicine , chemistry , pathology , genetics , outbreak , surgery , disease , infectious disease (medical specialty) , combinatorial chemistry

The content you want is available to Zendy users.

Already have an account? Click here to sign in.
Having issues? You can contact us here
Accelerating Research

Address

John Eccles House
Robert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom